Investors need to pay close attention to Genpact (G) stock based on the movements in the options market lately.

Genpact (NYSE: G) will report its financial results for the third quarter ended September 30, 2024 after the close of the U.S ...

Partners and clients across industries gather at exclusive eventNEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE: G ), a ...

Genpact (NYSE:G – Free Report) had its price objective boosted by Robert W. Baird from $38.00 to $44.00 in a research note ...

Genpact offices at 6737 Southpoint Drive S. in South Jacksonville. Genpact Ltd. said in a Sept. 26 notice under the Worker ...

Genpact Ltd (G) reports a robust quarter with increased revenue, improved margins, and a positive outlook for the year, ...

GenAI is undoubtedly changing how data scientists and analysts work, including tools, processes, and deliverables. Here’s ...

Speakers from Taktikal, Concentrix Catalyst, Genpact and NatWest Bank will be joining our speaker line-up at FinTech LIVE London ...

David Correa Allied Market Research +1 800-792-5285 email us here Visit us on social media: Facebook X ...

As a form of consulting company, Genpact is in a highly competitive industry and one with few barriers at the entry-level. Among its competitive advantages is its presence in India, which allows ...

(RTTNews) - Genpact Ltd. (G), an IT company, and Stada Arzneimittel AG (STDAY.PK, STDAF.PK), a maker of consumer healthcare, generic, and specialty pharma medicines, announced on Thursday that ...

and support regulatory compliance – ultimately enabling the company to continuously scale and excel in its industry." Since 2019, Genpact's partnership with STADA has centered on leveraging automation ...